Timothy R. Billiar

Clinical Biochemistry · 2000–2018

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Timothy R. Billiar trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Bianchi (in Clinical Biochemistry)

Papers from Timothy R. Billiar's perspective

Ordered by how strongly the researchers Timothy R. Billiar trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 (Proceedings of the National Academy of Sciences of the United States of America)
  2. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. (Cancer Cell)
  3. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature)
  4. Global Survey of Cell Death Mechanisms Reveals Metabolic Regulation of Ferroptosis (Nature Chemical Biology)
  5. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion (Journal of Experimental Medicine)
  6. Ferroptosis: Death by Lipid Peroxidation. (Trends in Cell Biology)
  7. Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models (Journal of the American Chemical Society)
  8. Acsl4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition (Nature Chemical Biology)
  9. Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis (eLife)
  10. DAMPs, PAMPs and alarmins: all we need to know about danger (Journal of Leukocyte Biology)

Their papers